Search

everythinglearnresearchcommunity

for

Search:↓

Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Balding men have higher heart disease risk.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

A gene called HDAC9 might be a new factor in male-pattern baldness.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

SHBG may be a useful early indicator and treatment target for PCOS.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Childhood growth hormone deficiency can be accurately diagnosed using gene expression data and random forest analysis.

Thyroid function may influence hair loss after COVID-19.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Sex hormones affect dog skin conditions, but more data is needed.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

A male with aromatase deficiency improved bone health with estradiol treatment.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Deslorelin implants successfully treated hair loss in two male Keeshonden dogs.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.